Suven Life Sciences Limited is a bio-pharmaceutical company. The Company is engaged in the business of manufacture and sale of bulk drugs and intermediaries. The Company's segments include Manufacturing (CRAMS), which develops and produces bulk drugs and intermediates under contract manufacturing services; Services (DDDSS), which consists of collaborative research projects (CRP), clinical trials, and testing and analysis services, and Research and Development. Its products consist of active pharmaceutical ingredients (APIs), including Aripiprazole, Armodafinil, Calcium Acetate, Carprofen, Deferasirox, Doxofylline, Entacapone, Fenoprofen Calcium, Rosuvastatin Calcium, Sitagliptin Phosphate and Solifenacin succinate, and intermediates, including 2-nitro phenyl acetic acid and 3, 4-dichlorobenzylamine. The Company is engaged in the drug discovery specializing in central nervous system (CNS)-based programs with over four of the molecules in pipeline under clinical phase of development.

Pharmaceutical

Suven Life Sciences Ltd

Venkat Jasti

Vitthal Gopnar

Viraj Dalal

Srinivas Reddy

Sreenu Vemula

Shital Ranvare

Sahithya Dasari

Mohan P

Mayur Khule

Mathi Phanni

Manuraj Ts

Manikandan Thangavel

Mahender Reddy

Drakshayani Badana

Bala Sri Vallika

Akhil Babu

Suresh Kumar Yalavarthi

Chinmay Durge

Padmakumar Kaimal

Vinod Goyal Dvm, Mvsc, Dabt

Jyothsna Ravula

Abdul Rasheed Mohammed

Sudharani Jasti

Suven Life Sciences Ltd's CEO and Executive Team includes Venkat Jasti.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Suven Life Sciences Ltd

Board of Directors

Leadership Team